Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Metagenomi

Biotech & Life Sciences · Emeryville, United States · Founded 2017 · IPO 2024 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$25M
Latest reported FY

Investors

23 investors on Metagenomi's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 8 investors entered at this stage
HOF Capital
Humboldt Fund
Agent Capital
Sozo Ventures
RA Capital Management
Bayer
Leaps by Bayer
InCube Ventures
Series B+ 15 investors entered at this stage
Novo Holdings
Frazier Healthcare Partners
SymBiosis
Bristol-Myers Squibb
Farallon Capital Management
Surveyor Capital
PFM Health Sciences
Deep Track Capital
Catalio Capital Management
Eventide Asset Management
Pura Vida Investments
Marshall Wace
Irving Investors
Moderna Therapeutics
Millennium Management

Global footprint

Where Metagenomi has talent and traffic

AI talent share
3.0% of workforce is AI talent
(5 of 164 staff)
Core AI21.22%
Other AI31.83%
Non-AI workforce15996.95%
Web traffic by country
6.1K monthly visits
across markets
🇺🇸 United States90.2%
🇮🇳 India9.8%
Top 2 markets shown

See Metagenomi on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo